APA (7th ed.) Citation

Nahi, H., Afram, G., Brauner, H., Talme, T., & Kuzmina, N. (2021). Pyoderma gangrenosum with plasma cell dyscrasia should be subject for anti‐myeloma treatment. International journal of dermatology, 60(7), e271-e273. https://doi.org/10.1111/ijd.15504

Chicago Style (17th ed.) Citation

Nahi, Hareth, Gabriel Afram, Hanna Brauner, Toomas Talme, and Natalia Kuzmina. "Pyoderma Gangrenosum with Plasma Cell Dyscrasia Should Be Subject for Anti‐myeloma Treatment." International Journal of Dermatology 60, no. 7 (2021): e271-e273. https://doi.org/10.1111/ijd.15504.

MLA (9th ed.) Citation

Nahi, Hareth, et al. "Pyoderma Gangrenosum with Plasma Cell Dyscrasia Should Be Subject for Anti‐myeloma Treatment." International Journal of Dermatology, vol. 60, no. 7, 2021, pp. e271-e273, https://doi.org/10.1111/ijd.15504.